Dubois-Stringfellow Nathalie

Dubois-Stringfellow Nathalie is listed in filings as SVP-CHIEF DEVELOPMENT OFFICER at Sangamo Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including sale activity. Recent filings connect the profile to Sangamo Therapeutics, Inc. (SGMO). The current snapshot covers public activity from Aug 27, 2024 to May 27, 2026. Reported amounts are shown as $703 to $208.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.